0000899243-19-002466.txt : 20190204 0000899243-19-002466.hdr.sgml : 20190204 20190204164627 ACCESSION NUMBER: 0000899243-19-002466 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190201 FILED AS OF DATE: 20190204 DATE AS OF CHANGE: 20190204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gross Paul Edward CENTRAL INDEX KEY: 0001766329 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35347 FILM NUMBER: 19564528 MAIL ADDRESS: STREET 1: 5500 FLATIRON PARKWAY, SUITE 100 CITY: BOULDER STATE: CO ZIP: 80302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clovis Oncology, Inc. CENTRAL INDEX KEY: 0001466301 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900475355 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (303) 625-5000 MAIL ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2019-02-01 0 0001466301 Clovis Oncology, Inc. CLVS 0001766329 Gross Paul Edward C/O CLOVIS ONCOLOGY, INC. 5500 FLATIRON PARKWAY, SUITE 100 BOULDER CO 80301 0 1 0 0 See Remarks Common Stock 2345 D Stock Option (right to buy) 22.99 2026-01-25 Common Stock 60000 D Stock Option (right to buy) 68.31 2027-03-27 Common Stock 15000 D Stock Option (right to buy) 58.43 2028-03-01 Common Stock 9000 D Restricted Stock Units 2027-03-27 Common Stock 4219 D Restricted Stock Units 2028-03-01 Common Stock 9000 D The option vested as to 25% of the shares on January 25, 2017, and the remainder vests in substantially equal installments over the 36 months immediately following such date. The option vested as to 25% of the shares on March 1, 2018, and the remainder vests in substantially equal installments over the 36 months immediately following such date. The option vests as to 25% of the shares on March 1, 2019, and the remainder vests in substantially equal installments over the 36 months immediately following such date. The Restricted Stock Units vested as to 25% of the units on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date. Each Restricted Stock Unit represents the right to receive one share of Common Stock. The Restricted Stock Units vest as to 25% of the units on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date. Executive Vice President, General Counsel and Chief Compliance Officer /s/ Paul Gross 2019-02-01